Related Experiment Videos
Analgesics and chronic renal disease
M J Klag1, P K Whelton, T V Perneger
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2223, USA.
Current Opinion in Nephrology and Hypertension
|May 1, 1996
Summary
Regular use of pain relievers like acetaminophen is linked to chronic kidney disease. Combinations of analgesics may pose the greatest risk to kidney health.
Area of Science:
- Nephrology
- Pharmacology
- Public Health
Background:
- Chronic kidney disease (CKD) is a significant public health concern.
- Analgesic medications are widely used for pain management.
- Previous research has indicated potential links between analgesic use and kidney damage.
Purpose of the Study:
- To review the association between analgesic intake and chronic renal diseases.
- To highlight specific analgesics and analgesic mixtures implicated in kidney damage.
- To inform healthcare providers and patients about analgesic risks to the kidney.
Main Methods:
- Review of existing case-control studies and scientific literature.
- Analysis of associations between specific analgesics (phenacetin, acetaminophen) and renal disease.
- Consideration of the impact of non-steroidal anti-inflammatory drugs (NSAIDs) and analgesic mixtures.
Main Results:
- Phenacetin was the first analgesic identified as a risk factor for chronic renal disease.
- Four out of five case-control studies show an association between acetaminophen use and kidney disease.
- Evidence suggests that analgesic mixtures are particularly harmful to kidney function.
- Long-term risks of NSAIDs are still under evaluation due to limited available data.
Conclusions:
- Analgesic use, particularly acetaminophen and mixtures, is associated with an increased risk of chronic kidney disease.
- Healthcare providers should be aware of these risks when prescribing or recommending analgesics.
- Patient education regarding safe analgesic use is crucial for kidney protection.